EyePoint Pharmaceuticals
EYPT
#6805
Rank
โ‚ฌ0.46 B
Marketcap
6,85ย โ‚ฌ
Share price
-0.28%
Change (1 day)
-63.74%
Change (1 year)

Revenue for EyePoint Pharmaceuticals (EYPT)

Revenue in 2024 (TTM): โ‚ฌ41.77 Million

According to EyePoint Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ44.1 Million. In 2023 the company made a revenue of โ‚ฌ41.62 Million an increase over the revenue in the year 2022 that were of โ‚ฌ38.59 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for EyePoint Pharmaceuticals from 2003 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ41.77 M0.34%
2023 โ‚ฌ41.62 M7.85%
2022 โ‚ฌ38.59 M18.34%
2021 โ‚ฌ32.61 M16.5%
2020 โ‚ฌ27.99 M54.02%
2019 โ‚ฌ18.17 M
2017 โ‚ฌ2.17 M-66.74%
2016 โ‚ฌ6.53 M313.39%
2015 โ‚ฌ1.58 M-93.16%
2014 โ‚ฌ23.11 M1354.94%
2013 โ‚ฌ1.58 M-11.52%
2012 โ‚ฌ1.79 M-63.36%
2011 โ‚ฌ4.9 M-61.94%
2010 โ‚ฌ12.87 M39.74%
2009 โ‚ฌ9.21 M42.8%
2008 โ‚ฌ6.45 M1154.57%
2007 โ‚ฌ0.51 M-67.06%
2006 โ‚ฌ1.56 M36.53%
2005 โ‚ฌ1.14 M259.02%
2004 โ‚ฌ0.31 M125.82%
2003 โ‚ฌ0.14 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.13 B 215.35%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A Bahamas